RxDoctor Payments Data

Pacificah Nyangau

Psychiatric/Mental Health · The Woodlands, TXNPI 1417516519

Payments from drug & device makers

$3,926in general payments, 2019–2025

Across 133 payments — averaging $29.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$924
  • AbbVie$905
  • Neurocrine Biosciences, Inc.$856
  • Teva Pharmaceuticals USA, Inc.$432
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$235
  • Vanda Pharmaceuticals Inc.$165
  • plus $408 from 8 others

What the payments were for

  • Food & beverage$3,926100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,926 in reported general payments places this provider in the 85th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas

Medicare billing

Part B allowed, 2024
$13,372
Medicare patients
43
Services billed
168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Duloxetine Hcl25$1,878
Desvenlafaxine Succinate ErDesvenlafaxine Succinate15$914
Mirtazapine28$912
Desipramine Hcl13$691
Lurasidone Hcl19$672
Quetiapine Fumarate61$583
Lamotrigine66$389
Divalproex Sodium14$344
Risperidone31$215
Alprazolam22$209
Bupropion XlBupropion Hcl24$199
Buspirone Hcl24$197
Trazodone Hcl68$192
Lithium Carbonate19$191
Hydroxyzine Hcl19$190

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in The Woodlands

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →